BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma
Claudia Pignataro(University of Naples Federico II), Danilo Fiore(Institute for Experimental Endocrinology and Oncology)
Cited by 2
Related Papers
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
|Nature Communications|2018|114